Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen

Product Details
Customization: Available
Certification: CE
Disinfection: Without Disinfection
Diamond Member Since 2020

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

to see all verified strength labels (14)
  • Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
  • Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
  • Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
  • Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
  • Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
  • Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
Find Similar Products
  • Overview
  • Product Description
  • Detailed Photos
  • Company Profile
Overview

Basic Info.

Model NO.
Lenisna
Color
White
Application
Face
Material
Plla
Transport Package
Box
Specification
200mg
Trademark
Lenisna
Origin
Korea
Production Capacity
1000000000

Product Description

Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
 
Product Description


 

LENISNA is one of the most effective tissue stimulants of collagen production known in aesthetic medicine - a protein responsible for hydration, firmness and elasticity of our skin, directly speaking for its youthful appearance. The strongest cross-linked hybrid filler available on the market, which combines the effect of immediate filling provided by hyaluronic acid and, thanks to the use of polylactic acid, stimulates the skin to produce collagen.
Lenisna is designed as a time-acting filler with a concentration of 170 mg PDLLA polylactic acid and 30 mg non-crosslinked hyaluronic acid. By adjusting the amount of solution and the size of particles from 50 to 60 micrometers with a round, porous shape and combining them with non-crosslinked hyaluronic acid, a hybrid was obtained suitable for application in the subcutaneous tissue or periosteum. It is intended for the treatment of deep wrinkles, flaccidity and significant tissue losses.
The Lenisna product, due to the high concentration of polylactic acid and hyaluronic acid, is used to increase the volume of sunken areas of the face, especially to correct skin depressions such as: skin folds, wrinkles, furrows, as well as in the case of visible signs of skin aging, drooping face and flaccidity. We can successfully use it on the inner side of the thighs, stomach, buttocks and sagging arms.
Indications for the procedure

  • skin with visible signs of aging,
  • sunken areas on the face,
  • furrows,
  • wrinkles, creases,
  • firming of flaccid facial skin,
  • firming the flabby skin of the arms (pelicans)
  • firming of the skin on the abdomen, thighs and buttocks
The positive effect is visible immediately after the procedure. The effects of the therapy last for at least 24 months after two/three treatments performed 6-8 weeks apart. The recommended number of treatments is 2. After 2 weeks, collagen production begins. The treatment is especially suitable for flaccid, atrophic skin, with a lot of fine wrinkles, with a small volume or with large volume losses. Polylactic acid slowly but systematically rejuvenates the skin, thickening it and making it more attractive and radiant. The effect is completely natural.
Application procedure:
  • Subcutaneously
  • Recommended cannula size: 22-25G or needle sizes: 25-26G.
  • It is applied to the subcutaneous tissue or periosteum
  • Feeding technique: deposit
  • Recommended number of sessions: 2-3 treatments 6-8 weeks apart.
Thanks to the patented manufacturing technology, the risk of subcutaneous lumps formed when using traditional PLLA has been eliminated. Durability of the procedure lasts about 2 years. Such a long period of action of Lenisna is undoubtedly an advantage of this product.
Composition:
  • Polylactic acid (PDLLA - Poly D, L Lactyd) 170mg - particle size 50-60 micrometers,
  • Non-crosslinked HA acid 30mg - particle size 3000 kDa.

The package contains: 1 ampoule of 5 ml
Product for use by professionals only.


 

Detailed Photos

Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product CollagenBuy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product CollagenBuy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product CollagenBuy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen

Company Profile

 

Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
Remarss company covers an area of 35000 square meters, of which the purification workshop is 8000 square meters.The company has independent research and development of Beijing university of more than 50 sets of advanced modern machinery and equipment, such as agnail cutting machine, automatic group installed, blister packing machine and so on.We also have more than 10 quality inspection personnel and 150 employees trained.The annual production capacity of pdo thread and hyaluronic acid company is 5 million pieces.



Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen
Related Products
Buy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product CollagenBuy Lenisna 200mg Soft Tissue Injectable Implant CE Hybrid Filler Combines Hyaluronic Acid with Polylactic Acid (PLA) to Stimulate Skin Product Collagen


 
 

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier